Ignite Creation Date:
2025-12-24 @ 11:53 PM
Ignite Modification Date:
2025-12-25 @ 9:49 PM
Study NCT ID:
NCT05876351
Status:
COMPLETED
Last Update Posted:
2025-12-08
First Post:
2023-05-17
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Eculizumab in Pediatric and Adult Participants With Atypical Hemolytic Uremic Syndrome (aHUS) in China
Sponsor:
Alexion Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-07-14
Start Date Type:
ACTUAL
Primary Completion Date:
2025-05-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-05-07
Completion Date Type:
ACTUAL
First Submit Date:
2023-05-17
First Submit QC Date:
None
Study First Post Date:
2023-05-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-11-17
Results First Submit QC Date:
None
Results First Post Date:
2025-12-08
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-05
Last Update Post Date:
2025-12-08
Last Update Post Date Type:
ESTIMATED